Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutationsFatima Karzai, William L. Dahut, Akira Yuno et al.|Journal for ImmunoTherapy of Cancer|2018Cited by 312